Skip to main content

Insulet signals beyond the news: 68+ signals from 5 sources

The latest Insulet signal on this page is from Sep 29, 2026 (Patents): "INSULET CORPORATION's patent output is accelerating: 64 grants in the past year, 10 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).

Public (PODD)Medical Equipment Manufacturing1,001 to 5,000 employeesinsulet.comLinkedIn

Signals
68+
Sources
5
Last 90 days
27
Latest
Sep 29, 2026

Other signals · latest 10

Latest Insulet signals by source

68+ signals for Insulet across 5 sources.

  1. Patents · Patent pace

    INSULET CORPORATION's patent output is accelerating: 64 grants in the past year, 10 in the past 30 days.

    Over the past year INSULET CORPORATION received 64 US patent grants, concentrated in health tech / medical informatics and autonomous control systems; the recent pace (19 in 90 days) is accelerating versus its trailing baseline.

    Grants, 12 months
    64
    Grants, 90 days
    19
    Grants, 30 days
    10
    Pace
    Accelerating

    Google Patents

  2. Patents · Patent grant

    Insulet was granted a patent for adaptive insulin therapy settings.

    In September 2026 Insulet patented a diabetes-management method for adjusting insulin recommendations based on glucose variability in connected delivery devices.

    Patent title
    Adjusting insulin therapy setting based on variability of blood glucose values
    Grant date
    Sep 29, 2026
    Inventors
    Alexandra Elena Constantin
    Tech area
    health tech / medical informatics

    Google Patents

  3. Glassdoor · Competitive market pressure

    Company revenue growth challenged by competitors and cost-cutting layoffs

    One review states that company revenue growth is being challenged by other competitors and that layoffs are becoming common as a cost-cutting measure.

    Overall rating
    3.8 of 5
    CEO approval
    59%
    Reviews read
    8
    Review window
    Aug 13, 2026 to Sep 1, 2026

    Glassdoor

  4. Glassdoor · Consistent leadership complaints

    Leadership and management face significant criticism for poor execution and politics

    Multiple reviews criticize leadership for poor execution, political dynamics, inconsistent decision-making, and lack of accountability. One reviewer states that Director level people lack basic business skills and leadership is disappointing.

    Overall rating
    3.8 of 5
    CEO approval
    59%
    Reviews read
    8
    Review window
    Aug 13, 2026 to Sep 1, 2026

    Glassdoor

  5. Website changes · Customer win

    Insulet strengthened its customer-centric messaging by replacing the prior customer-focused image with a new customer group photo and changing the description to emphasize transforming lives.

    The image changed from “Our Podders gather with our team” to “Group of Insulet customers standing in front of a photo booth and mango backdrop,” while the copy changed from “Our relentless desire to simplify lives” to “Our relentless desire to transform lives.”

    Page
    /innovation

    insulet.com

  6. Website changes · Event announcement

    Insulet added prominent promotional content highlighting its Pod booth at ATTD 2026.

    The innovation page replaced the prior image with “2026-07/SCR_200_Innovation_ATTD_Pod_Booth_06_2026.jpg” and the alt text “Insulet's Pod booth at ATTD 2026.”

    Page
    /innovation

    insulet.com

  7. LinkedIn

    Insulet welcomes Jorge Leon as Senior Manager of Social Impact focusing on health equity.

    Please join us in welcoming Jorge Leon to Team Insulet!​ ​ Jorge joins us as Senior Manager of Social Impact, bringing a genuine passion for health equity and community well-being to his work. In his role, Jorge will focus on creating meaningful, positive change in the communities where we live and work, advocating...

    Likes
    84
    Comments
    3
    Tags
    Sustainability
    Initiatives
    driving initiatives for healthier communities, advocating for equitable diabetes care

    LinkedIn

  8. LinkedIn

    Insulet expresses gratitude to healthcare professionals for advancing diabetes care at ADA2026.

    From our team to yours - thank you, #ADA2026.​ Being together, connecting, learning, and sharing our collective expertise, is what fuels our passion for what we do every day.​ To every healthcare professional who stopped by the Omnipod® booth or joined our sessions, thank you for your time, your thoughtful...

    Likes
    287
    Comments
    1
    Tags
    Medical Research, Telemedicine
    Initiatives
    simplifying diabetes management, making diabetes management more effective, making diabetes management more impactful

    LinkedIn

  9. YouTube

    Insulet Corp ($PODD) Q3 2025 Earnings Call

    Insulet Corp discusses its Q3 2025 earnings results in an official earnings call.

    Channel
    Castify Earnings Call
    Views
    2
    Comments
    0
    Tags
    Earnings Call, Medical Devices

    YouTube (Castify Earnings Call)

  10. YouTube

    Insulet Omnipod 5 Explained | Tubeless Insulin Pump Revolution for Diabetes

    Insulet explains Omnipod 5, a tubeless insulin pump with an automated insulin delivery system.

    Channel
    Wealth Dynasty
    Views
    19
    Comments
    0
    Tags
    Product Launch, Diabetes Technology, Medical Device

    YouTube (Wealth Dynasty)

Showing 10 of 68+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Insulet with the Signal API

One POST /v1/companies/enrich call with insulet.com returns Insulet signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "insulet.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Same industry

Questions about Insulet other signals

What signals does Autobound track for Insulet besides news and filings?
This page lists 68+ signals for Insulet from 5 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), YouTube (12) and Patents (11). Every row is dated, and most link to the post, review or record.
What are people saying about Insulet online?
The newest posts on this page: May 11, 2026, YouTube (YouTube (Castify Earnings Call)): Insulet Corp ($PODD) Q3 2025 Earnings Call. May 11, 2026, YouTube (YouTube (Wealth Dynasty)): Insulet Omnipod 5 Explained | Tubeless Insulin Pump Revolution for Diabetes. May 11, 2026, YouTube (YouTube (Castify Earnings Call)): Insulet Corp ($PODD) Q4 2025 Earnings Call.
What do employees say about working at Insulet?
The newest Glassdoor theme on this page, dated Sep 1, 2026: Company revenue growth challenged by competitors and cost-cutting layoffs. The overall rating in that row is 3.8 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Insulet been granted patents recently?
Yes. The newest grant on this page: Sep 29, 2026, Patents (Google Patents): Insulet was granted a patent for adaptive insulin therapy settings.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →